Skip to main content
. 2019 Mar 14;9:4545. doi: 10.1038/s41598-019-41118-z

Figure 1.

Figure 1

Trial Flow Diagram. A total of 1,212 eligible patients underwent laboratory assays and ultrasonography at baseline. Among them, 1008 participants (499 and 509 in the TXL and placebo group, respectively) completed the study follow-up.